UPSC Exams
Latest Update
Coaching
UPSC Current Affairs
Syllabus
UPSC Notes
Previous Year Papers
UPSC Mains Previous Year Question Papers Last 25 Years UPSC Prelims Question Papers Last 10 Years UPSC Question Papers UPSC CSE Prelims 2025 Question Paper UPSC Mains 2024 Model Answers UPSC 2024 Question Papers UPSC 2023 Question Papers UPSC 2022 Question Papers UPSC 2021 Question Papers UPSC 2020 Question Papers UPSC 2019 Question Papers UPSC 2018 Question Papers UPSC 2017 Question Papers UPSC 2016 Question Papers UPSC 2015 Question Papers UPSC 2014 Question Papers UPSC CSAT Question Papers UPSC IFS Previous Year Paper UPSC Assistant Labour Commissioner Previous Question Year Papers UPSC Combined Geo Scientist Previous Year Paper UPSC APFC Previous Year Question Papers UPSC CMS Previous Year Question Paper UPSC EPFO Previous Year Paper UPSC Air Safety Officer Previous Year Papers UPSC SO Steno Previous Year Paper UPSC IES ISS Previous Year Question Papers
Mock Tests
UPSC Editorial
Bilateral Ties
Albania India Relations India Algeria Relations Andorra India Relations India Angola Relations India Antigua Barbuda Relations India Argentina Relations Austria India Relations India Azerbaijan Relations Bahamas India Relations India Bahrain Relations Barbados India Relations India Belarus Relations Belgium India Relations Belize India Relations Benin India Relations Bolivia India Relations India Bosnia Herzegovina Relations India Botswana Relations Brazil India Relations Brunei India Relations Bulgaria India Relations Burundi India Relations Cabo Verde India Relations India Cambodia Relations India Cameroon Relations Canada India Relations India Cayman Islands Relations India Central African Republic Relations India Chad Relations Chile India Relations India Colombia Relations India Comoros Relations India Democratic Republic Of The Congo Relations India Republic Of The Congo Relations India Cook Islands Relations India Costa Rica Relations India Ivory Coast Relations India Croatia Relations India Cyprus Relations India Czech Republic Relations India Djibouti Relations India Dominica Relations India Dominican Republic Relations India Ecuador Relations India El Salvador Relations India Equatorial Guinea Relations India Eritrea Relations Estonia India Relations India Ethiopia Relations India Fiji Relations India Finland Relations India Gabon Relations India Gambia Relations India Georgia Relations Germany India Relations India Ghana Relations India Greece Relations India Grenada Relations India Guatemala Relations India Guinea Relations India Guinea Bissau Relations India Guyana Relations India Haiti Relations India Holy See Relations India Honduras Relations India Hong Kong Relations India Hungary Relations India Iceland Relations India Indonesia Relations India Iran Relations India Iraq Relations India Ireland Relations India Jamaica Relations India Kazakhstan Relations India Kenya Relations India Kingdom Of Eswatini Relations India Kiribati Relations India Kuwait Relations India Kyrgyzstan Relations India Laos Relations Latvia India Relations India Lebanon Relations India Lesotho Relations India Liberia Relations Libya India Relations Liechtenstein India Relations India Lithuania Relations India Luxembourg Relations India Macao Relations Madagascar India Relations India Malawi Relations India Mali Relations India Malta Relations India Marshall Islands Relations India Mauritania Relations India Micronesia Relations India Moldova Relations Monaco India Relations India Montenegro Relations India Montserrat Relations India Morocco Relations Mozambique India Relations India Namibia Relations India Nauru Relations Netherlands India Relations India Nicaragua Relations India Niger Relations India Nigeria Relations India Niue Relations India North Macedonia Relations Norway India Relations India Palau Relations India Panama Relations India Papua New Guinea Relations India Paraguay Relations Peru India Relations India Philippines Relations Qatar India Relations India Romania Relations Rwanda India Relations India Saint Kitts And Nevis Relations India Saint Lucia Relations India Saint Vincent And Grenadines Relations India Samoa Relations India Sao Tome And Principe Relations Saudi Arabia India Relations India Senegal Relations Serbia India Relations India Sierra Leone Relations India Singapore Relations India Slovak Republic Relations India Slovenia Relations India Solomon Islands Relations Somalia India Relations India South Sudan Relations India Spain Relations India Sudan Relations Suriname India Relations India Sweden Relations India Syria Relations India Tajikistan Relations Tanzania India Relations India Togo Relations India Tonga Islands Relations India Trinidad And Tobago Relations India Tunisia Relations India Turkmenistan Relations India Turks And Caicos Islands Relations India Tuvalu Relations India Uganda Relations India Ukraine Relations India Uae Relations India Uruguay Relations India Uzbekistan Relations India Vanuatu Relations India Venezuela Relations India British Virgin Islands Relations Yemen India Relations India Zambia Relations India Zimbabwe Relations
Books
Government Schemes
Production Linked Incentive Scheme Integrated Processing Development Scheme Rodtep Scheme Amended Technology Upgradation Fund Scheme Saathi Scheme Uday Scheme Hriday Scheme Samagra Shiksha Scheme India Nishta Scheme Stand Up India Scheme Sahakar Mitra Scheme Mdms Mid Day Meal Scheme Integrated Child Protection Scheme Vatsalya Scheme Operation Green Scheme Nai Roshni Scheme Nutrient Based Subsidy Scheme Kalia Scheme Ayushman Sahakar Scheme Nirvik Scheme Fame India Scheme Kusum Scheme Pm Svanidhi Scheme Pmvvy Scheme Pm Aasha Scheme Pradhan Mantri Mahila Shakti Kendra Scheme Pradhan Mantri Lpg Panjayat Scheme Mplads Scheme Svamitva Scheme Pat Scheme Udan Scheme Ek Bharat Shresth Bharat Scheme National Pension Scheme Ujala Scheme Operation Greens Scheme Gold Monetisation Scheme Family Planning Insurance Scheme Target Olympic Podium Scheme
Topics
NASA Space Missions
NASA Mercury-Redstone 3 (Freedom 7) Mission NASA Mercury-Redstone 4 (Liberty Bell 7) Mission NASA Mercury-Atlas 6 (Friendship 7) Mission NASA Mercury-Atlas 7 (Aurora 7) Mission NASA Mercury-Atlas 8 (Sigma 7) Mission NASA Mercury-Atlas 9 (Faith 7) Mission NASA Gemini 3 Mission NASA Gemini 4 Mission NASA Gemini 5 Mission NASA Gemini 7 Mission NASA Gemini 8 Mission NASA Gemini 9 Mission NASA Gemini 10 Mission NASA Gemini 11 Mission NASA Gemini 12 Mission NASA Apollo 1 (AS‑204) Mission NASA Apollo 7 Mission NASA Apollo 8 Mission NASA Apollo 9 Mission NASA Apollo 10 Mission NASA Apollo 11 Mission NASA Apollo 12 Mission NASA Apollo 13 Mission NASA Apollo 14 Mission NASA Apollo 15 Mission NASA Apollo 16 Mission NASA Apollo 17 Mission NASA Skylab Orbital Workshop Mission NASA Skylab 2 Mission NASA Skylab 3 Mission NASA Skylab 4 Mission NASA Apollo–Soyuz Test Project Mission NASA STS‑1 Columbia Mission NASA STS‑3 Columbia Mission NASA STS‑7 Challenger Mission NASA STS‑8 Challenger Mission NASA STS‑41B Challenger Mission NASA STS‑41G Discovery (1st female EVA) Mission NASA STS‑51L Challenger (accident) Mission NASA STS‑26 Discovery (Return‑to‑Flight) Mission NASA STS‑31 Discovery (Hubble Launch) Mission NASA STS‑49 Endeavour (first capture EVA) Mission NASA STS‑61 Endeavour (Hubble Servicing 1) Mission NASA STS‑73 Columbia (microgravity) Mission NASA STS‑95 Discovery (John Glenn returns) Mission NASA STS‑107 Columbia (accident) Mission NASA STS‑114 Discovery (RTF‑2) Mission NASA STS‑120 Discovery (Node 2) Mission NASA STS‑125 Atlantis (Final Hubble Service) Mission NASA STS‑132 Atlantis Mission NASA STS‑135 Atlantis (Final Shuttle flight) Mission NASA Artemis I (Orion/ SLS‑1) Mission NASA Artemis II (Planned) Mission NASA Artemis III (Planned lunar landing) Mission NASA Mariner 4 Mission NASA Mariner 6 Mission NASA Mariner 7 Mission NASA Mariner 9 Mission NASA Viking 1 Orbiter/Lander Mission NASA Viking 2 Orbiter/Lander Mission NASA Mars Pathfinder & Sojourner Mission NASA Mars Global Surveyor Mission NASA 2001 Mars Odyssey Mission NASA Mars Exploration Rover – Spirit Mission NASA Mars Exploration Rover – Opportunity Mission NASA Mars Reconnaissance Orbiter Mission NASA Phoenix Mars Lander Mission NASA InSight Mars Lander Mission NASA Mars 2020 (Perseverance & Ingenuity) Mission NASA Mars Sample Return – SRL (planned) Mission NASA Pioneer 10 Mission NASA Pioneer 11 Mission NASA Voyager 1 Mission NASA Voyager 2 Mission NASA Galileo Jupiter Orbiter/Probe Mission NASA Cassini–Huygens Mission NASA New Horizons (Pluto & KBO) Mission NASA Juno Mission NASA Europa Clipper (planned) Mission NASA Parker Solar Probe Mission NASA Solar Orbiter (ESA/NASA) Mission NASA Surveyor 1 Mission NASA Lunar Orbiter 1 Mission NASA Lunar Prospector Mission NASA LCROSS Mission NASA LADEE Mission NASA Lunar Reconnaissance Orbiter (LRO) Mission NASA CAPSTONE Mission NASA VIPER Rover (planned) Mission NASA NEAR Shoemaker Mission NASA Deep Space 1 Mission NASA Stardust Mission NASA Genesis Mission NASA Deep Impact Mission NASA Dawn (Vesta/Ceres) Mission NASA OSIRIS‑REx Mission NASA Lucy Mission NASA DART Mission NASA Landsat‑1 (ERTS‑1) Mission NASA Landsat‑5 Mission NASA Landsat‑9 Mission NASA Terra Mission NASA Aqua Mission NASA Aura Mission NASA Suomi NPP Mission NASA Sentinel‑6 Michael Freilich Mission NASA ICESat‑2 Mission NASA GRACE‑FO Mission NASA SMAP Mission NASA GPM Core Observatory Mission NASA CALIPSO Mission NASA CloudSat Mission NASA NISAR (NASA‑ISRO) Mission NASA Explorer 1 Mission NASA COBE Mission NASA Compton Gamma Ray Observatory Mission NASA Hubble Space Telescope Mission NASA Chandra X‑ray Observatory Mission NASA Spitzer Space Telescope Mission NASA WISE Mission NASA Kepler Mission NASA TESS Mission NASA Fermi Gamma‑ray Space Telescope Mission NASA NICER Mission NASA IXPE Mission NASA Roman Space Telescope (planned) Mission NASA NuSTAR Mission NASA GALEX Mission NASA Swift Mission NASA SOHO (ESA/NASA) Mission NASA Cluster II (ESA/NASA) Mission NASA TIMED Mission NASA STEREO‑A/B Mission NASA MMS Mission NASA IRIS Mission NASA Solar Dynamics Observatory Mission NASA X‑37B OTV‑1 (USAF/NASA liaison) Mission NASA X‑59 QueSST Mission NASA Mars Helicopter Ingenuity Mission NASA Valkyrie R5 Robot Mission NASA Low‑Boom Flight Demo Mission NASA CRS‑1 Dragon Mission NASA CRS‑1 Cygnus Mission NASA Crew Dragon Demo‑2 Mission NASA Starliner OFT‑2 Mission NASA STS-2 (Shuttle flight) Mission NASA STS-4 (Shuttle flight) Mission NASA STS-5 (Shuttle flight) Mission NASA STS-6 (Shuttle flight) Mission NASA STS-41C (Shuttle flight) Mission NASA STS-41D (Shuttle flight) Mission NASA STS-51A (Shuttle flight) Mission NASA STS-61C (Shuttle flight) Mission NASA STS-26 (Shuttle flight) Mission NASA STS-27 (Shuttle flight) Mission NASA STS-29 (Shuttle flight) Mission NASA STS-30 (Shuttle flight) Mission NASA STS-32 (Shuttle flight) Mission NASA STS-34 (Shuttle flight) Mission NASA STS-38 (Shuttle flight) Mission NASA STS-45 (Shuttle flight) Mission NASA STS-60 (Shuttle flight) Mission NASA STS-70 (Shuttle flight) Mission NASA STS-71 (Shuttle flight) Mission NASA STS-73 (Shuttle flight) Mission NASA STS-88 (Shuttle flight) Mission NASA STS-92 (Shuttle flight) Mission NASA STS-97 (Shuttle flight) Mission NASA STS-99 (Shuttle flight) Mission NASA STS-100 (Shuttle flight) Mission NASA STS-104 (Shuttle flight) Mission NASA STS-106 (Shuttle flight) Mission NASA STS-110 (Shuttle flight) Mission NASA STS-112 (Shuttle flight) Mission NASA STS-115 (Shuttle flight) Mission NASA STS-116 (Shuttle flight) Mission NASA STS-117 (Shuttle flight) Mission NASA STS-118 (Shuttle flight) Mission NASA STS-120 (Shuttle flight) Mission NASA STS-122 (Shuttle flight) Mission NASA STS-123 (Shuttle flight) Mission NASA STS-126 (Shuttle flight) Mission NASA STS-130 (Shuttle flight) Mission NASA Vanguard 1 Mission NASA Transit 1B Mission NASA Echo 1 Mission NASA Telstar 1 Mission NASA Syncom 3 Mission NASA ATS‑6 Mission NASA Skynet Mission NASA Nimbus‑1 Mission NASA Nimbus‑7 Mission NASA ERS-1 Mission NASA SeaSat Mission NASA QuikSCAT Mission NASA Jason‑1 Mission NASA Jason‑3 Mission NASA ICESat Mission NASA Earth Observing‑1 Mission NASA Orbiting Carbon Observatory‑2 Mission NASA CYGNSS Mission NASA PACE Mission NASA TRMM Mission NASA Terrestrial Planet Finder (cxl) Mission NASA Laser Interferometer Space Antenna (LISA) Mission NASA Explorer 33 Mission NASA Voyager Interstellar Mission Mission NASA Helios‑A Mission NASA Helios‑B Mission NASA ISEE‑3 (ICE) Mission NASA ACE Mission NASA DSCOVR Mission NASA IBEX Mission NASA Solar Orbiter Heliospheric Imager Mission NASA SAGE‑III ISS Mission NASA SPACE Telescope Imaging Spectrograph Mission NASA ARIEL (ESA/NASA) Mission NASA OSAM‑1 (Restore‑L) Mission NASA Dragonfly (Titan rotorcraft) Mission NASA VERITAS (Venus orbiter) Mission NASA DAVINCI (Venus probe) Mission NASA SPHEREx Mission NASA MAGGIE (Mars Geophysical) Mission NASA CLPS – Peregrine Mission NASA CLPS – VIPER Delivery Mission NASA CAPSTONE Mission NASA Gateway (HALO / PPE) Mission NASA Mars Telecommunication Orbiter (cxl) Mission NASA Mars Polar Lander (MPL) Mission NASA Mars Climate Orbiter Mission NASA Pathfinder Mission Mission NASA SLS Block 1B (Exploration Upper Stage) Mission NASA Orion Crew Module Mission NASA Commercial LEO Destinations – Axiom Station Mission NASA ISS Expedition 1 Mission NASA ISS Expedition 70 Mission NASA CRS‑11 (Dragon) Mission NASA CRS‑21 (Dragon 2) Mission NASA Snoopy CubeSat Mission

Bulk Drug Parks - Selection of Bulk Drug Parks, Aims, Objectives, Significance And More

Last Updated on Sep 06, 2023
Download As PDF
IMPORTANT LINKS

Bulk Drug Parks are specialized industrial zones dedicated to manufacturing bulk drugs or active pharmaceutical ingredients (APIs). These parks are designed to provide a conducive environment to attract pharmaceutical companies. These parks help promote the domestic production of essential drugs. The Central government of India has granted 'in principle' approval for three bulk drug parks. These are located in Gujarat, Himachal Pradesh, and Andhra Pradesh. These parks aim to ensure a steady availability of essential drug components. 

In this article, we shall discuss information on the meaning, significance, and other facts about the bulk drug parks in India given below.

This is an important topic for the upcoming UPSC Exams, and aspirants should understand the importance, benefits, and other facts about the bulk drug parks in India. This topic is important for General Studies Paper 1 of the UPSC prelims exam and General Studies Paper 2 and GS Paper 3 of the Main examination.

Latest News about the Bulk Drug Park
  • The Department of Pharmaceuticals has established a high-level committee to track the development of bulk drug parks in three states. Mansukh Mandaviya, Union Minister of Chemical and Fertilizer, is in charge of the high-level committee. Minister of State Bhagwanth Khuba is vice chairman, and other top officials, including business experts, are also members.
  • In October 2022, the Prime Minister of India laid the foundation stone of the bulk drug park in Una, Himachal Pradesh. It is expected to generate investment of roughly Rs. 10,000 crores and employ more than 20,000 people. It will also have a positive effect on the local economy.
  • The first bulk drug park in India was set up in Jambusar of Bharuch district, Gujarat.

Also, read about Atal Tinkering Labs for the UPSC Exam here!

FREEMentorship Program by
Ravi Kapoor, Ex-IRS
UPSC Exam-Hacker, Author, Super Mentor, MA
100+ Success Stories
Key Highlights
Achieve your Goal with our mentorship program, offering regular guidance and effective exam strategies.
Cultivate a focused mindset for exam success through our mentorship program.
UPSC Beginners Program

Get UPSC Beginners Program SuperCoaching @ just

₹50000

Claim for free

What is Bulk Drug Park?

A Bulk Drug Park is a place where bulk drugs or APIs (Active Pharmaceutical Ingredients) are manufactured in huge quantities. These drugs are used in the manufacture of medicines. Bulk Drug Parks are set up by the government to promote the manufacturing of bulk drugs in India.

Controlling Ministry

The Ministry of Chemicals and Fertilizers (Department of Pharmaceuticals) will be the controlling ministry for the Scheme for promoting bulk drug parks. The concerned State Government would set up a State Implementing Agency (SIA), a legal entity, to carry out the scheme. The day-to-day operation of bulk drug parks shall be under the control of the SIA.

Selection of Bulk Drug Parks

13 States submitted proposals under the scheme for promoting bulk drug parks. To evaluate the proposals, the Department of Pharmaceuticals was advised by an advisory committee under the CEO of NITI Aayog.

As per the proposals submitted by the States, three states got ‘in-principle approval from the Centre to establish bulk drug parks. Bulk drug parks will be set up in the following States:

  • In 1402.44 acres of land at Tehsil Haroli, District Una, Himachal Pradesh
  • 2015.02 acres of land at Tehsil Jambusar, District Bharuch, Gujarat and
  • 2000.45 acres of land at K.P. Puram & Kodhada of Thondagi Mandal of East Godavari District, Andhra Pradesh.

Know more about Drug Abuse!

What is Bulk Drug?

An Active Pharmaceutical Ingredient (API), often known as a bulk drug, is the vital component of a medicine that gives it the desired therapeutic effect or causes the intended pharmacological activity. For instance: One common bulk drug that serves to treat pain is paracetamol. It is combined with binding agents or solvents to produce the paracetamol tablet (the finished product).

What is Active Pharmaceutical Ingredient (API)?

An active Pharmaceutical Ingredient (API) is a biologically active component in pharmaceutical drugs that produce the intended therapeutic effect. They are the key chemical substances responsible for the pharmacological activity of the medication. APIs are typically synthesized through chemical processes or derived from natural sources. They undergo rigorous testing and must meet specific quality standards before they can be used to produce pharmaceutical formulations.

Types of APIs

There are several types of APIs:

  • Synthetic APIs are chemically synthesized in laboratories.
  • Biotechnological APIs, also known as biologics, are derived from living organisms.
  • Semi-synthetic APIs are a combination of natural and synthetic components.
  • Plant-based APIs are derived from plants and their extracts.
  • Marine-based APIs are derived from marine organisms.
  • Radiopharmaceutical APIs are radioactive substances used in nuclear medicine.

Key Starting Material (KSM)

Key Starting Material (KSM) refers to a crucial raw material used in an active pharmaceutical ingredient's synthesis or manufacturing process (API). KSMs are the foundational components that undergo chemical transformations and reactions to yield the desired API. They play a pivotal role in producing APIs, serving as the starting point or precursor for the synthesis pathway. The quality and purity of KSMs are of utmost importance to ensure the integrity and efficacy of the final API. KSMs are typically carefully selected and subjected to rigorous quality control measures to meet the pharmaceutical industry's specific requirements and regulatory standards.

Drug Intermediate (DI)

A Drug Intermediate (DI) is a chemical compound produced and used during a pharmaceutical drug's synthesis or manufacturing process. DIs are intermediate compounds formed as part of a series of reactions and transformations that ultimately produce the final Active Pharmaceutical Ingredient (API). These intermediates have specific chemical structures and properties that make them suitable for further modifications and conversions to obtain the desired API.

Also, check out Types of Vaccines for the UPSC Exam!

Reason Behind the Promotion of Bulk Drug Parks by the Indian Government

The Indian government's scheme to promote Bulk Drug Parks has several reasons behind it:

  • Reduce dependence on imported Active Pharmaceutical Ingredients (APIs).
  • Enhance self-sufficiency in pharmaceutical manufacturing.
  • Strengthen the domestic pharmaceutical industry.
  • Ensure a consistent and reliable supply of essential drugs.
  • Boost drug security and reduce vulnerability to supply chain disruptions.
  • Create employment opportunities in the pharmaceutical sector.
  • Promote innovation and collaboration in the industry.
  • Facilitate cost-effective production through shared facilities and economies of scale.
  • Promote the export of pharmaceutical products and contribute to the country's economy.
  • Improve the availability and affordability of medicines for the population.

Know more about Orphan Drugs!

Aims and Objectives of Bulk Drug Parks

The aims and objectives for setting up bulk drug parks in India are given below:

  • These parks will offer common infrastructural facilities in one location, developing a robust ecosystem for India’s bulk drug manufacturing.
  • To reduce the manufacturing cost of bulk drugs by creating world-class common infrastructure facilities.
  • To increase the competitiveness of the domestic manufacturing of bulk drugs and decrease import dependence
  • To establish a dominant position in the global market by providing easy access to standard testing and infrastructure facilities
  • To assist the industry in achieving environmental standards at a lower cost by using innovative approaches of the common waste management system and using the benefits brought about by resource optimization and economies of scale.

Also, read about the United Nations Office on Drugs and Crime UNODC for the UPSC Exam.

Significance of Bulk Drug Parks

The significance of establishing bulk drug parks is given below:

  • This will make India self-reliant in APIs and drug intermediates and minimize India’s dependence on imports.
  • Give a fillip to indigenous manufacturing of crucial raw materials for medicines and increase the competitiveness of the domestic bulk drug industry.
  • Will bring down the cost of manufacturing bulk drugs
  • Help in the production of quality raw materials.
  • Increase the competitiveness of the domestic bulk drug industry.
  • Provide quality and affordable medical care to people.
  • Lead to more investment and employ people.
  • Ensure a continuous supply of high-quality bulk drugs and boost India’s ability to scale up its production in an emergency.

Read about Drug Price Control Order for the UPSC exams.

Key Facts and Figures about Bulk Drug Parks

Important facts related to the bulk drug parks and the scheme for the promotion of bulk drug parks are given below in the table below:

Bulk Drug Parks: Key Facts and Figures for UPSC

1

What is a bulk drug park?

As per the scheme, a bulk drug park is a defined contiguous parcel of land with common infrastructural facilities for the sole purpose of manufacturing APIs, DIs, or KSMs.

2

What is the purpose of setting up a bulk drug park?

The common infrastructure facilities created under the scheme will help reduce the manufacturing cost of bulk drugs and also enhance the competitiveness of the domestic industry. It will help India become self-reliant and less dependent on the import of bulk drugs.

3

Which Ministry and Department implement the Scheme for the promotion of bulk drug parks?

The Department of Pharmaceuticals under the Ministry of Chemicals and Fertilizers

4

What is the Scheme for the promotion of bulk drug parks?

  • This is a Central Sector Scheme with a total financial outlay of Rs. 3000 Crore.

5

When was the scheme for the promotion of bulk drug parks launched?

The scheme was approved by the Government of India on March 20, 2020.

6

What is the maximum limit of financial assistance given by the central government to states to set up bulk drug parks?

The proposed bulk drug park in Gujarat and Andhra Pradesh would get financial support equal to 70% of the project’s cost for common infrastructure facilities. Himachal Pradesh would receive financial support equal to 90% of the project cost because it is a hilly state. The most that can be provided under the scheme for one bulk drug park is Rs. 1000 crores.

7

What is the rank of the Indian pharmaceutical industry by volume?

The pharmaceutical industry in India ranks third in the world in terms of volume. In the fiscal year 2021–2022, India exported pharmaceuticals worth Rs. 1,75,040 crore, comprising bulk drugs and drug intermediates.

8

Is India a producer of Active Pharma Ingredients (API) or bulk drugs in the world?

One of the world’s top producers of active pharmaceutical ingredients (API) or bulk drugs is India. In the fiscal year 2021–2022, India exported bulk drugs/drug intermediates worth Rs. 33,320 crores. However, in 2021-22, bulk drugs accounted for over 60 percent of total pharmaceutical imports.

10

What are the examples of APIs?

The APIs include:

  • Cephalosporins
  • steroids,
  • inorganic salt
  • proton pump inhibitors
  • Analgesics
  • Antipyretics
  • Anti-inflammatory drugs like paracetamol, diclofenac sodium, aceclofenac, ibuprofen etc

Check out this article on Genetic Engineering for UPSC here!

Conclusion

Implementing the bulk drug park promotion scheme will help India become self-sufficient in APIs and drug intermediates in the long run. It will lower the cost of bulk drugs and make healthcare more affordable. The establishment of bulk drug parks that produce quality raw materials per industry standards will help grow the Indian pharmaceutical industry in India.

Download the PDF on Bulk Drug Parks notes for UPSC Exam here.

Check the article on Maternal and Neonatal Tetanus for the UPSC Exams!

Testbook provides a set of comprehensive notes for different competitive exams. Testbook is always on the top of the list because of its best quality assured products like live tests, mocks, Content pages, GK and current affairs videos, and much more. To study more topics for UPSC, download the Testbook App now. For further information and an explanation of the topic, visit UPSC CSE Coaching here!

More Articles for IAS Preparation

Bulk Drug Park FAQs

The first bulk drug park in India was set up in Jambusar of Bharuch district, Gujarat. The foundation stone for the second bulk drug park was inaugurated at Haroli in Una district, Himachal Pradesh.

The aim of establishing bulk drug parks in India is to make India self-reliant in the sourcing of pharmaceutical raw materials. The scheme will help in import substitution.

3 Till September 1, 2022, ‘in-principle’ approval has been given to the proposals of three States, that is, Gujarat, Himachal Pradesh, and Andhra Pradesh under the Scheme for “Promotion of Bulk Drug Parks”.

Bulk drugs are often known as Active Pharmaceutical Ingredients (APIs). These are vital components of a drug that give it the desired therapeutic effect or cause the intended pharmacological activity, whereas Key Starting Material (KSM) is the primary raw material or the key chemical that undergoes reactions to form an API.

The Scheme for the Promotion of Bulk Drug Parks is implemented by the Ministry of Chemicals and Fertilizers.

Report An Error